HawkEye 360, Inc. has recently reported the granting of restricted stock units (RSUs) to its board member William Joseph Burns, as detailed in a filing with the SEC. This action, taken on November 10, 2026, signifies the company's ongoing commitment to incentivizing its directors and aligning their interests with the long-term growth of the firm.
The move is particularly relevant as it showcases how HawkEye 360, a company categorized under Services-Computer Processing & Data Preparation, is adapting to industry standards in executive compensation. By granting RSUs, the company aims to enhance its governance structure and potentially attract more talent in a competitive landscape.
Background
HawkEye 360, Inc. is a technology company that specializes in data processing and preparation services. The company operates under the ticker symbol HAWK on the NYSE and is classified under the SIC code 7374. As a non-accelerated filer and an emerging growth company, HawkEye 360 is positioned to innovate within its sector.
What the Filing Says
The SEC filing dated November 13, 2026, outlines the details of the RSU grant to Burns. According to the filing, "Represents restricted stock units (RSUs) granted pursuant to the Issuer's 2026 Equity Incentive Plan (the 'Plan'). The RSUs will vest in three equal annual installments beginning on November 10, 2027, subject to the Continuous Service of the Reporting Person as of each applicable vesting date." This grant was made in accordance with the company's non-employee director compensation policy.
Impact
This development may affect various stakeholders, including the company's board members, investors, and employees. By aligning the interests of board members with the company's long-term performance, HawkEye 360 may enhance its overall governance and operational effectiveness. Such strategic decisions could also influence investor confidence and market perception.
What's Next
The filing does not say what happens next.
Read Next
Mataac Lara sells 5,000 shares of OneSpan Inc. stock
Astera Labs director sells over 10,000 shares of stock
David Sidransky Exercises Stock Options at Champions Oncology
Carl Russo Sells Shares in Calix, Inc. Amid Market Adjustments
Evertec EVP Brignardello Daniel Reports Stock Transaction
Stata Ray Sells 1,000 Shares of Analog Devices Stock








